Firefly Luciferase - RPMI 8226 Recombinant Cell Line | 79834

Firefly Luciferase - RPMI 8226 Recombinant Cell Line | 79834 | Gentaur US, UK & Europe Disrtribition

Category: Immunotherapy/Immunotherapy Cell Line & Cell-Based Assay Kit

Application: Use as a control for co-culture killing assays.

Background: RPMI 8226 cells are human B cells isolated from a plasmacytoma/myeloma patient. RPMI 8226 cells constitutively express B-Cell Maturation Antigen (BCMA), and offer a physiologically relevant platform to evaluate cancer-directed immunotherapies, such as Chimeric Antigen Receptor (CAR) T cells. The Firefly Luciferase - RPMI 8226 Recombinant Cell Line makes an excellent target to measure specific killing of CAR-T or NK cells targeting BCMA.

Description: Recombinant RPMI 8226 cells constitutively expressing firefly (Photinus pyralis) luciferase.

Product Type: Cell Line

Shippement Condition: -80°C